Medicale Corp
MCLE · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4 | $6 | $15 | $16 |
| SG&A Expenses | $4 | $6 | $15 | $16 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $4 | $6 | $15 | $16 |
| Operating Income | -$4 | -$6 | -$11 | -$16 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$2 | -$2 | -$2 | -$1 |
| Pre-Tax Income | -$6 | -$8 | -$17 | -$17 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6 | -$8 | -$13 | -$17 |
| % Margin | – | – | – | – |
| EPS | -0.001 | -0.001 | -0.002 | 0.007 |
| % Growth | 35.7% | 33.3% | -130% | – |
| EPS Diluted | -0.001 | -0.001 | -0.002 | 0.007 |
| Weighted Avg Shares Out | 5,920 | 5,920 | 5,920 | 5,920 |
| Weighted Avg Shares Out Dil | 5,920 | 5,920 | 5,920 | 5,920 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2 | $2 | $2 | $1 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$4 | -$6 | -$11 | -$16 |
| % Margin | – | – | – | – |